Note: Ingredients listed on restricted chemical lists
EC/CAS
811-97-2
Name of the chemical
1,1,1,2-Tetrafluoroethane
Concentration
≥25-≤50
EC/CAS
138495-42-8
Name of the chemical
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro
Concentration
≥25-≤50
EC/CAS
460-73-1
Name of the chemical
1,1,1,3,3-Pentafluoropropane
Concentration
≤5
General Information
Version
19
Revision date
2026-08-10
Product name
EL2206 ELECTRO WIZARD Electronic Contact Cleaner Aerosol
Manufacturer Name
Sprayon Products Group
Emergency telephone
(800) 424-9300
Icons in SDS
Company Information
company name
Sprayon Products Group
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H229
Hazard statements
Code
Statements
H229
Pressurized container: may burst if heated
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
52.6% (oral), 52.6% (dermal), 3.6% (inhalation)
Signal word
Warning
Hazard statements
Pressurized container: may burst if heated.
Prevention
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Do not pierce or burn, even after use.
Response
Not applicable.
Storage
Protect from sunlight. Do not expose to temperatures exceeding 122 °F/50 °C.
Disposal
Not applicable.
Supplemental label elements
DELAYED EFFECTS FROM LONG TERM OVEREXPOSURE. Contains solvents which can cause permanent brain and nervous system damage. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal. FOR INDUSTRIAL USE ONLY. This product contains a TSCA regulated chemical. See Section 15 of the US SDS for details. Please refer to the SDS for additional information. Keep out of reach of children. Keep upright in a cool, dry place. Do not discard empty can in trash compactor.
2.3 Other hazards
None known. Hazards identified when used : No known significant effects or critical hazards.
2.1 Classification of the substance or mixture
substance or mixture Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 52.6% (oral), 52.6% (dermal), 3.6% (inhalation)
